{{ $DoctorName }} @if (isset(session()->get('doctor')['vCentralCode'])) {{ session()->get('doctor')['vCentralCode'] }} @endif
@if (isset(session()->get('doctor')['vCentralCode']))
Logout
@endif

{{ $ActivityTypeName }}

{{ $ActivityName }}

@csrf
@if (isset(session()->get('doctor')['vCentralCode']))
Back
@else
@endif

SurveY to assess multifactorial approach for reductioN in risk of complications in diabEtes based on Routine manaGement strategY among healthcare practitioners (SYNERGY)

  1. What is your approach in addressing the multiple cardiovascular risk factors (glycemic control, blood pressure and lipid control) in patients with diabetes mellitus? *

  2. In your daily practice, how many patients do you see on an average with uncontrolled T2DM? *

  3. How do you rate the adherence of diabetic patients to lifestyle modifications? *

  4. In your opinion, which of these patient factors are most related to development of co-morbidities in a T2DM patient of India origin? (Can select more than one) *

  5. In diabetic hypertensive patients which lifestyle modification is most effective? *

  6. How effective is the dietary modification for glycaemic control in diabetes? *

  7. In your opinion how effective are the diabetes specific nutrition shakes in improving the glycaemic control in diabetic patents? *

  8. In diabetic patients uncontrolled on metformin which is your preferred agent for combination therapy? *

  9. What benefits do you observe in your patients, when prescribed a fixed dose combination (FDC)? *

  10. What is the single-most benefit that you observe when initiating your patient on a FDC at the start of the therapy? *

  11. Have you observed any of these benefits in continued usage of these FDCs? (Can select multiple) *

  12. What percentage of your patients develop complications due to diabetes? *

  13. What is your preferred test for screening of ASCVD risk in patients with diabetes? *

  14. What systolic blood pressure do you target in your diabetic patients ? *

  15. What diastolic blood pressure do you target in your diabetic patients? *

  16. What agents do you prefer as first line treatment for hypertension in patients with diabetes? *

  17. In which cases do you order a lipid profile evaluation? *

  18. In which group of diabetic patients do you initiate statin therapy? *

  19. In patients who do not tolerate statin therapy what is your preferred approach? *

  20. In diabetic patients with previously documented ASCVD what is the LDL-C levels that you target? *

  21. What is your preferred approach in diabetic patients who do not achieve target LDL-C goals on statin therapy? *

  22. As per your clinical experience, which are the key unmet medical needs in patients with type 2 diabetes mellitus with multiple cardiovascular risk factors? *

  23. Among your diabetes patients what proportion of patients also have heart failure ? *

  24. In your opinion does the rate of hospitalizations due to heart failure more among diabetic patients high? *

  25. In patients with diabetes and established ASCVD/ASCVD risk factors which is your preferred oral antidiabetic agent? *

  26. In which patients do you prefer screening for microalbuminuria? *

  27. Which test do you prefer to screen diabetic patients for CKD? *

  28. What frequency of testing do you recommend for testing of GFR and albuminuria in patients with diabetes? *

  29. In patients with diabetes and chronic kidney disease which is your preferred agent? *

  30. In which patients do you prefer to initiate finerenone therapy? *

  31. In patients with mineralocorticoid receptor antagonist how often do you monitor serum potassium levels? *

  32. In elderly diabetic patients with multiple co-existing chronic illnesses or mild to moderate cognitive impairment what is the HBA1c goal do you target? *

  33. In which patients do you recommend the use of continuous glucose monitoring (CGM)? (multiple options can be selected) *

  34. What is your opinion on the utility of bariatric surgery in obese diabetic patients? *

  35. In your opinion which patients can be considered for beta cell replacement therapy (islet cell transplantation or whole pancreas transplantation)? (Mark all that are applicable) *